> top > docs > PubMed:3925894 > annotations
TextAE configuration unavailable!

PubMed:3925894 JSONTXT

Annnotations TAB JSON ListView MergeView

spacy-test

Id Subject Object Predicate Lexical cue
spaCy_T0 0-10 NNP denotes Lymphocyte
spaCy_T1 11-17 NN denotes subset
spaCy_T2 18-24 NNS denotes ratios
spaCy_T3 25-28 CC denotes and
spaCy_T4 29-35 NN denotes factor
spaCy_T5 36-40 NNP denotes VIII
spaCy_T6 41-46 NN denotes usage
spaCy_T7 47-49 IN denotes in
spaCy_T8 50-61 NN denotes haemophilia
spaCy_T9 61-62 . denotes .
spaCy_T10 63-67 NN denotes Type
spaCy_T11 68-71 CC denotes and
spaCy_T12 72-80 NN denotes quantity
spaCy_T13 81-83 IN denotes of
spaCy_T14 84-95 NN denotes replacement
spaCy_T15 96-105 NN denotes treatment
spaCy_T16 105-106 , denotes ,
spaCy_T17 107-115 RB denotes together
spaCy_T18 116-120 IN denotes with
spaCy_T19 121-135 JJ denotes haematological
spaCy_T20 136-139 CC denotes and
spaCy_T21 140-153 JJ denotes immunological
spaCy_T22 154-164 NNS denotes parameters
spaCy_T23 165-169 VBD denotes were
spaCy_T24 170-180 VBN denotes determined
spaCy_T25 181-183 IN denotes in
spaCy_T26 184-186 CD denotes 37
spaCy_T27 187-191 NNS denotes boys
spaCy_T28 192-196 IN denotes with
spaCy_T29 197-203 JJ denotes severe
spaCy_T30 204-215 NN denotes haemophilia
spaCy_T31 216-217 DT denotes A
spaCy_T32 218-221 CC denotes and
spaCy_T33 222-224 CD denotes 41
spaCy_T34 225-233 NNS denotes children
spaCy_T35 234-238 IN denotes with
spaCy_T36 239-244 JJ denotes other
spaCy_T37 245-253 VBG denotes bleeding
spaCy_T38 254-263 NNS denotes disorders
spaCy_T39 263-264 . denotes .
spaCy_T40 265-268 DT denotes The
spaCy_T41 269-277 NN denotes quantity
spaCy_T42 278-280 IN denotes of
spaCy_T43 281-287 NN denotes factor
spaCy_T44 288-292 NNP denotes VIII
spaCy_T45 293-304 NN denotes concentrate
spaCy_T46 305-310 VBN denotes given
spaCy_T47 311-313 TO denotes to
spaCy_T48 314-318 NNS denotes boys
spaCy_T49 319-323 IN denotes with
spaCy_T50 324-330 JJ denotes severe
spaCy_T51 331-342 NN denotes haemophilia
spaCy_T52 343-344 DT denotes A
spaCy_T53 345-346 -LRB- denotes (
spaCy_T54 346-350 VB denotes mean
spaCy_T55 351-357 NNP denotes U/year
spaCy_T56 357-358 -RRB- denotes )
spaCy_T57 359-365 VBD denotes showed
spaCy_T58 366-367 DT denotes a
spaCy_T59 368-379 JJ denotes significant
spaCy_T60 380-387 NN denotes inverse
spaCy_T61 388-399 NN denotes correlation
spaCy_T62 400-404 IN denotes with
spaCy_T63 405-410 JJ denotes total
spaCy_T64 411-416 JJ denotes white
spaCy_T65 417-421 NN denotes cell
spaCy_T66 422-428 NNS denotes counts
spaCy_T67 428-429 , denotes ,
spaCy_T68 430-440 NN denotes lymphocyte
spaCy_T69 441-447 NNS denotes counts
spaCy_T70 447-448 , denotes ,
spaCy_T71 449-457 NN denotes platelet
spaCy_T72 458-464 NNS denotes counts
spaCy_T73 464-465 , denotes ,
spaCy_T74 466-469 CC denotes and
spaCy_T75 470-473 DT denotes the
spaCy_T76 474-479 NN denotes ratio
spaCy_T77 480-482 IN denotes of
spaCy_T78 483-493 JJ denotes monoclonal
spaCy_T79 494-502 NN denotes antibody
spaCy_T80 503-510 VBN denotes defined
spaCy_T81 511-512 NNP denotes T
spaCy_T82 513-523 NN denotes lymphocyte
spaCy_T83 524-531 NNS denotes subsets
spaCy_T84 531-532 , denotes ,
spaCy_T85 533-535 CD denotes T4
spaCy_T86 536-539 CC denotes and
spaCy_T87 540-542 CD denotes T8
spaCy_T88 543-544 -LRB- denotes (
spaCy_T89 544-546 CD denotes T4
spaCy_T90 546-547 : denotes :
spaCy_T91 547-549 CD denotes T8
spaCy_T92 549-550 -RRB- denotes )
spaCy_T93 550-551 . denotes .
spaCy_T94 552-554 IN denotes Of
spaCy_T95 555-558 DT denotes the
spaCy_T96 559-563 NNS denotes boys
spaCy_T97 564-568 IN denotes with
spaCy_T98 569-575 JJ denotes severe
spaCy_T99 576-587 NNS denotes haemophilia
spaCy_T100 588-589 DT denotes A
spaCy_T101 589-590 , denotes ,
spaCy_T102 591-593 CD denotes 49
spaCy_T103 593-594 NN denotes %
spaCy_T104 595-598 VBD denotes had
spaCy_T105 599-607 VBN denotes inversed
spaCy_T106 608-610 CD denotes T4
spaCy_T107 610-611 : denotes :
spaCy_T108 611-613 CD denotes T8
spaCy_T109 614-620 NNS denotes ratios
spaCy_T110 621-624 CC denotes and
spaCy_T111 625-627 CD denotes 24
spaCy_T112 627-628 NN denotes %
spaCy_T113 629-632 VBD denotes had
spaCy_T114 633-649 NN denotes thrombocytopenia
spaCy_T115 649-650 . denotes .
spaCy_T116 651-660 NNP denotes Treatment
spaCy_T117 661-665 IN denotes with
spaCy_T118 666-670 JJ denotes high
spaCy_T119 671-675 NN denotes dose
spaCy_T120 676-682 NN denotes factor
spaCy_T121 683-687 NNP denotes VIII
spaCy_T122 688-699 NN denotes concentrate
spaCy_T123 700-701 -LRB- denotes (
spaCy_T124 701-705 JJR denotes more
spaCy_T125 706-710 IN denotes than
spaCy_T126 711-713 CD denotes 25
spaCy_T127 714-717 CD denotes 000
spaCy_T128 718-724 NNP denotes U/year
spaCy_T129 724-725 -RRB- denotes )
spaCy_T130 726-729 VBD denotes was
spaCy_T131 730-740 VBN denotes associated
spaCy_T132 741-745 IN denotes with
spaCy_T133 746-749 JJ denotes low
spaCy_T134 750-758 NN denotes platelet
spaCy_T135 759-765 NNS denotes counts
spaCy_T136 765-766 , denotes ,
spaCy_T137 767-770 JJ denotes low
spaCy_T138 771-781 NN denotes lymphocyte
spaCy_T139 782-788 NNS denotes counts
spaCy_T140 788-789 , denotes ,
spaCy_T141 790-793 JJ denotes low
spaCy_T142 794-796 CD denotes T4
spaCy_T143 796-797 : denotes :
spaCy_T144 797-799 CD denotes T8
spaCy_T145 800-806 NNS denotes ratios
spaCy_T146 806-807 , denotes ,
spaCy_T147 808-811 CC denotes and
spaCy_T148 812-835 NN denotes hypergammaglobulinaemia
spaCy_T149 835-836 . denotes .
spaCy_T150 837-839 IN denotes In
spaCy_T151 840-848 NN denotes addition
spaCy_T152 848-849 , denotes ,
spaCy_T153 850-853 CD denotes six
spaCy_T154 854-862 NNS denotes patients
spaCy_T155 863-867 IN denotes with
spaCy_T156 868-874 JJ denotes severe
spaCy_T157 875-886 NN denotes haemophilia
spaCy_T158 887-888 DT denotes A
spaCy_T159 889-892 CC denotes and
spaCy_T160 893-899 NN denotes factor
spaCy_T161 900-904 NNP denotes VIII
spaCy_T162 905-915 NNS denotes inhibitors
spaCy_T163 916-919 VBD denotes had
spaCy_T164 920-928 VBN denotes inversed
spaCy_T165 929-931 CD denotes T4
spaCy_T166 931-932 : denotes :
spaCy_T167 932-934 CD denotes T8
spaCy_T168 935-941 NNS denotes ratios
spaCy_T169 941-942 . denotes .
spaCy_T170 943-951 NNS denotes Patients
spaCy_T171 952-959 VBD denotes treated
spaCy_T172 960-971 RB denotes exclusively
spaCy_T173 972-976 IN denotes with
spaCy_T174 977-992 NN denotes cryoprecipitate
spaCy_T175 993-995 CC denotes or
spaCy_T176 996-1007 NN denotes prothrombin
spaCy_T177 1008-1015 JJ denotes complex
spaCy_T178 1016-1028 VBZ denotes concentrates
spaCy_T179 1029-1032 VBD denotes had
spaCy_T180 1033-1039 JJ denotes normal
spaCy_T181 1040-1042 CD denotes T4
spaCy_T182 1042-1043 : denotes :
spaCy_T183 1043-1045 CD denotes T8
spaCy_T184 1046-1052 NNS denotes ratios
spaCy_T185 1053-1056 CC denotes and
spaCy_T186 1057-1065 NN denotes platelet
spaCy_T187 1066-1072 NNS denotes counts
spaCy_T188 1072-1073 . denotes .
spaCy_T189 1074-1077 DT denotes The
spaCy_T190 1078-1086 NN denotes severity
spaCy_T191 1087-1089 IN denotes of
spaCy_T192 1090-1093 DT denotes the
spaCy_T193 1094-1108 JJ denotes haematological
spaCy_T194 1109-1112 CC denotes and
spaCy_T195 1113-1126 JJ denotes immunological
spaCy_T196 1127-1140 NNS denotes abnormalities
spaCy_T197 1141-1149 VBD denotes observed
spaCy_T198 1150-1155 VBZ denotes seems
spaCy_T199 1156-1158 TO denotes to
spaCy_T200 1159-1161 VB denotes be
spaCy_T201 1162-1172 VBN denotes associated
spaCy_T202 1173-1177 IN denotes with
spaCy_T203 1178-1182 JJ denotes high
spaCy_T204 1183-1188 NN denotes usage
spaCy_T205 1189-1191 IN denotes of
spaCy_T206 1192-1198 NN denotes factor
spaCy_T207 1199-1203 NNP denotes VIII
spaCy_T208 1204-1216 VBZ denotes concentrates
spaCy_T209 1216-1217 . denotes .
spaCy_T210 1218-1225 JJ denotes Similar
spaCy_T211 1226-1239 NNS denotes abnormalities
spaCy_T212 1240-1244 VBP denotes have
spaCy_T213 1245-1249 VBN denotes been
spaCy_T214 1250-1259 VBN denotes described
spaCy_T215 1260-1262 IN denotes in
spaCy_T216 1263-1271 NNS denotes patients
spaCy_T217 1272-1276 IN denotes with
spaCy_T218 1277-1280 DT denotes the
spaCy_T219 1281-1289 VBN denotes acquired
spaCy_T220 1290-1296 JJ denotes immune
spaCy_T221 1297-1307 NN denotes deficiency
spaCy_T222 1308-1316 NN denotes syndrome
spaCy_T223 1317-1318 -LRB- denotes (
spaCy_T224 1318-1322 NNP denotes AIDS
spaCy_T225 1322-1323 -RRB- denotes )
spaCy_T226 1323-1324 . denotes .
spaCy_T227 1325-1336 JJ denotes Prospective
spaCy_T228 1337-1342 NN denotes study
spaCy_T229 1343-1345 IN denotes of
spaCy_T230 1346-1359 NNS denotes haemophiliacs
spaCy_T231 1360-1362 VBZ denotes is
spaCy_T232 1363-1371 VBN denotes required
spaCy_T233 1372-1374 TO denotes to
spaCy_T234 1375-1381 VB denotes assess
spaCy_T235 1382-1386 JJ denotes long
spaCy_T236 1387-1391 NN denotes term
spaCy_T237 1392-1400 NN denotes sequelae
spaCy_T238 1401-1403 IN denotes of
spaCy_T239 1404-1410 NN denotes factor
spaCy_T240 1411-1422 NN denotes concentrate
spaCy_T241 1423-1428 NN denotes usage
spaCy_T242 1428-1429 , denotes ,
spaCy_T243 1430-1439 VBG denotes including
spaCy_T244 1440-1443 DT denotes the
spaCy_T245 1444-1452 JJ denotes possible
spaCy_T246 1453-1464 NN denotes development
spaCy_T247 1465-1467 IN denotes of
spaCy_T248 1468-1472 NNP denotes AIDS
spaCy_T249 1472-1473 . denotes .
spaCy_R27 spaCy_T27 spaCy_T25 pobj boys,in
spaCy_R28 spaCy_T28 spaCy_T27 prep with,boys
spaCy_R29 spaCy_T29 spaCy_T30 amod severe,haemophilia
spaCy_R0 spaCy_T0 spaCy_T2 compound Lymphocyte,ratios
spaCy_R1 spaCy_T1 spaCy_T2 compound subset,ratios
spaCy_R2 spaCy_T2 spaCy_T2 ROOT ratios,ratios
spaCy_R3 spaCy_T3 spaCy_T2 cc and,ratios
spaCy_R4 spaCy_T4 spaCy_T2 conj factor,ratios
spaCy_R5 spaCy_T5 spaCy_T6 compound VIII,usage
spaCy_R6 spaCy_T6 spaCy_T6 ROOT usage,usage
spaCy_R7 spaCy_T7 spaCy_T6 prep in,usage
spaCy_R8 spaCy_T8 spaCy_T7 pobj haemophilia,in
spaCy_R9 spaCy_T9 spaCy_T6 punct .,usage
spaCy_R10 spaCy_T10 spaCy_T24 nsubjpass Type,determined
spaCy_R11 spaCy_T11 spaCy_T10 cc and,Type
spaCy_R12 spaCy_T12 spaCy_T10 conj quantity,Type
spaCy_R13 spaCy_T13 spaCy_T12 prep of,quantity
spaCy_R14 spaCy_T14 spaCy_T15 compound replacement,treatment
spaCy_R15 spaCy_T15 spaCy_T13 pobj treatment,of
spaCy_R16 spaCy_T16 spaCy_T12 punct ",",quantity
spaCy_R17 spaCy_T17 spaCy_T18 advmod together,with
spaCy_R18 spaCy_T18 spaCy_T10 prep with,Type
spaCy_R19 spaCy_T19 spaCy_T22 amod haematological,parameters
spaCy_R20 spaCy_T20 spaCy_T19 cc and,haematological
spaCy_R21 spaCy_T21 spaCy_T19 conj immunological,haematological
spaCy_R22 spaCy_T22 spaCy_T18 pobj parameters,with
spaCy_R23 spaCy_T23 spaCy_T24 auxpass were,determined
spaCy_R24 spaCy_T24 spaCy_T24 ROOT determined,determined
spaCy_R25 spaCy_T25 spaCy_T24 prep in,determined
spaCy_R26 spaCy_T26 spaCy_T27 nummod 37,boys
spaCy_R30 spaCy_T30 spaCy_T31 compound haemophilia,A
spaCy_R31 spaCy_T31 spaCy_T28 pobj A,with
spaCy_R32 spaCy_T32 spaCy_T31 cc and,A
spaCy_R33 spaCy_T33 spaCy_T34 nummod 41,children
spaCy_R34 spaCy_T34 spaCy_T31 conj children,A
spaCy_R35 spaCy_T35 spaCy_T34 prep with,children
spaCy_R36 spaCy_T36 spaCy_T38 amod other,disorders
spaCy_R37 spaCy_T37 spaCy_T38 amod bleeding,disorders
spaCy_R38 spaCy_T38 spaCy_T35 pobj disorders,with
spaCy_R39 spaCy_T39 spaCy_T24 punct .,determined
spaCy_R40 spaCy_T40 spaCy_T41 det The,quantity
spaCy_R41 spaCy_T41 spaCy_T57 nsubj quantity,showed
spaCy_R42 spaCy_T42 spaCy_T41 prep of,quantity
spaCy_R43 spaCy_T43 spaCy_T42 pobj factor,of
spaCy_R44 spaCy_T44 spaCy_T45 compound VIII,concentrate
spaCy_R45 spaCy_T45 spaCy_T57 nsubj concentrate,showed
spaCy_R46 spaCy_T46 spaCy_T45 acl given,concentrate
spaCy_R47 spaCy_T47 spaCy_T46 dative to,given
spaCy_R48 spaCy_T48 spaCy_T47 pobj boys,to
spaCy_R49 spaCy_T49 spaCy_T46 prep with,given
spaCy_R50 spaCy_T50 spaCy_T51 amod severe,haemophilia
spaCy_R51 spaCy_T51 spaCy_T52 compound haemophilia,A
spaCy_R52 spaCy_T52 spaCy_T57 nsubj A,showed
spaCy_R53 spaCy_T53 spaCy_T54 punct (,mean
spaCy_R54 spaCy_T54 spaCy_T52 parataxis mean,A
spaCy_R55 spaCy_T55 spaCy_T54 dep U/year,mean
spaCy_R56 spaCy_T56 spaCy_T54 punct ),mean
spaCy_R57 spaCy_T57 spaCy_T57 ROOT showed,showed
spaCy_R58 spaCy_T58 spaCy_T61 det a,correlation
spaCy_R59 spaCy_T59 spaCy_T61 amod significant,correlation
spaCy_R60 spaCy_T60 spaCy_T61 compound inverse,correlation
spaCy_R61 spaCy_T61 spaCy_T57 dobj correlation,showed
spaCy_R62 spaCy_T62 spaCy_T61 prep with,correlation
spaCy_R63 spaCy_T63 spaCy_T66 amod total,counts
spaCy_R64 spaCy_T64 spaCy_T66 amod white,counts
spaCy_R65 spaCy_T65 spaCy_T66 compound cell,counts
spaCy_R66 spaCy_T66 spaCy_T62 pobj counts,with
spaCy_R67 spaCy_T67 spaCy_T66 punct ",",counts
spaCy_R68 spaCy_T68 spaCy_T69 compound lymphocyte,counts
spaCy_R69 spaCy_T69 spaCy_T66 conj counts,counts
spaCy_R70 spaCy_T70 spaCy_T69 punct ",",counts
spaCy_R71 spaCy_T71 spaCy_T72 compound platelet,counts
spaCy_R72 spaCy_T72 spaCy_T69 conj counts,counts
spaCy_R73 spaCy_T73 spaCy_T72 punct ",",counts
spaCy_R74 spaCy_T74 spaCy_T72 cc and,counts
spaCy_R75 spaCy_T75 spaCy_T76 det the,ratio
spaCy_R76 spaCy_T76 spaCy_T72 conj ratio,counts
spaCy_R77 spaCy_T77 spaCy_T76 prep of,ratio
spaCy_R78 spaCy_T78 spaCy_T79 amod monoclonal,antibody
spaCy_R79 spaCy_T79 spaCy_T77 pobj antibody,of
spaCy_R80 spaCy_T80 spaCy_T76 acl defined,ratio
spaCy_R81 spaCy_T81 spaCy_T83 compound T,subsets
spaCy_R82 spaCy_T82 spaCy_T83 compound lymphocyte,subsets
spaCy_R83 spaCy_T83 spaCy_T80 dobj subsets,defined
spaCy_R84 spaCy_T84 spaCy_T83 punct ",",subsets
spaCy_R85 spaCy_T85 spaCy_T83 conj T4,subsets
spaCy_R86 spaCy_T86 spaCy_T85 cc and,T4
spaCy_R87 spaCy_T87 spaCy_T85 conj T8,T4
spaCy_R88 spaCy_T88 spaCy_T89 punct (,T4
spaCy_R89 spaCy_T89 spaCy_T85 appos T4,T4
spaCy_R90 spaCy_T90 spaCy_T85 punct :,T4
spaCy_R91 spaCy_T91 spaCy_T85 appos T8,T4
spaCy_R92 spaCy_T92 spaCy_T85 punct ),T4
spaCy_R93 spaCy_T93 spaCy_T57 punct .,showed
spaCy_R94 spaCy_T94 spaCy_T94 ROOT Of,Of
spaCy_R95 spaCy_T95 spaCy_T96 det the,boys
spaCy_R96 spaCy_T96 spaCy_T94 pobj boys,Of
spaCy_R97 spaCy_T97 spaCy_T96 prep with,boys
spaCy_R98 spaCy_T98 spaCy_T99 amod severe,haemophilia
spaCy_R99 spaCy_T99 spaCy_T97 pobj haemophilia,with
spaCy_R100 spaCy_T100 spaCy_T100 ROOT A,A
spaCy_R101 spaCy_T101 spaCy_T105 punct ",",inversed
spaCy_R102 spaCy_T102 spaCy_T103 nummod 49,%
spaCy_R103 spaCy_T103 spaCy_T105 nsubj %,inversed
spaCy_R104 spaCy_T104 spaCy_T105 aux had,inversed
spaCy_R105 spaCy_T105 spaCy_T113 ccomp inversed,had
spaCy_R106 spaCy_T106 spaCy_T105 advmod T4,inversed
spaCy_R107 spaCy_T107 spaCy_T106 punct :,T4
spaCy_R108 spaCy_T108 spaCy_T109 nummod T8,ratios
spaCy_R109 spaCy_T109 spaCy_T105 npadvmod ratios,inversed
spaCy_R110 spaCy_T110 spaCy_T109 cc and,ratios
spaCy_R111 spaCy_T111 spaCy_T112 nummod 24,%
spaCy_R112 spaCy_T112 spaCy_T113 nsubj %,had
spaCy_R113 spaCy_T113 spaCy_T113 ROOT had,had
spaCy_R114 spaCy_T114 spaCy_T113 dobj thrombocytopenia,had
spaCy_R115 spaCy_T115 spaCy_T113 punct .,had
spaCy_R116 spaCy_T116 spaCy_T131 nsubjpass Treatment,associated
spaCy_R117 spaCy_T117 spaCy_T116 prep with,Treatment
spaCy_R118 spaCy_T118 spaCy_T120 amod high,factor
spaCy_R119 spaCy_T119 spaCy_T120 compound dose,factor
spaCy_R120 spaCy_T120 spaCy_T122 compound factor,concentrate
spaCy_R121 spaCy_T121 spaCy_T122 compound VIII,concentrate
spaCy_R122 spaCy_T122 spaCy_T117 pobj concentrate,with
spaCy_R123 spaCy_T123 spaCy_T122 punct (,concentrate
spaCy_R124 spaCy_T124 spaCy_T127 amod more,000
spaCy_R125 spaCy_T125 spaCy_T127 quantmod than,000
spaCy_R126 spaCy_T126 spaCy_T127 compound 25,000
spaCy_R127 spaCy_T127 spaCy_T128 nummod 000,U/year
spaCy_R128 spaCy_T128 spaCy_T122 appos U/year,concentrate
spaCy_R129 spaCy_T129 spaCy_T122 punct ),concentrate
spaCy_R130 spaCy_T130 spaCy_T131 auxpass was,associated
spaCy_R131 spaCy_T131 spaCy_T131 ROOT associated,associated
spaCy_R132 spaCy_T132 spaCy_T131 prep with,associated
spaCy_R133 spaCy_T133 spaCy_T135 amod low,counts
spaCy_R134 spaCy_T134 spaCy_T135 compound platelet,counts
spaCy_R135 spaCy_T135 spaCy_T132 pobj counts,with
spaCy_R136 spaCy_T136 spaCy_T135 punct ",",counts
spaCy_R137 spaCy_T137 spaCy_T139 amod low,counts
spaCy_R138 spaCy_T138 spaCy_T139 compound lymphocyte,counts
spaCy_R139 spaCy_T139 spaCy_T135 conj counts,counts
spaCy_R140 spaCy_T140 spaCy_T139 punct ",",counts
spaCy_R141 spaCy_T141 spaCy_T142 amod low,T4
spaCy_R142 spaCy_T142 spaCy_T131 npadvmod T4,associated
spaCy_R143 spaCy_T143 spaCy_T142 punct :,T4
spaCy_R144 spaCy_T144 spaCy_T145 nummod T8,ratios
spaCy_R145 spaCy_T145 spaCy_T142 appos ratios,T4
spaCy_R146 spaCy_T146 spaCy_T145 punct ",",ratios
spaCy_R147 spaCy_T147 spaCy_T145 cc and,ratios
spaCy_R148 spaCy_T148 spaCy_T145 conj hypergammaglobulinaemia,ratios
spaCy_R149 spaCy_T149 spaCy_T131 punct .,associated
spaCy_R150 spaCy_T150 spaCy_T164 prep In,inversed
spaCy_R151 spaCy_T151 spaCy_T150 pobj addition,In
spaCy_R152 spaCy_T152 spaCy_T164 punct ",",inversed
spaCy_R153 spaCy_T153 spaCy_T154 nummod six,patients
spaCy_R154 spaCy_T154 spaCy_T164 nsubj patients,inversed
spaCy_R155 spaCy_T155 spaCy_T154 prep with,patients
spaCy_R156 spaCy_T156 spaCy_T157 amod severe,haemophilia
spaCy_R157 spaCy_T157 spaCy_T158 compound haemophilia,A
spaCy_R158 spaCy_T158 spaCy_T155 pobj A,with
spaCy_R159 spaCy_T159 spaCy_T158 cc and,A
spaCy_R160 spaCy_T160 spaCy_T158 conj factor,A
spaCy_R161 spaCy_T161 spaCy_T162 compound VIII,inhibitors
spaCy_R162 spaCy_T162 spaCy_T164 nsubj inhibitors,inversed
spaCy_R163 spaCy_T163 spaCy_T164 aux had,inversed
spaCy_R164 spaCy_T164 spaCy_T164 ROOT inversed,inversed
spaCy_R165 spaCy_T165 spaCy_T164 dobj T4,inversed
spaCy_R166 spaCy_T166 spaCy_T165 punct :,T4
spaCy_R167 spaCy_T167 spaCy_T168 nummod T8,ratios
spaCy_R168 spaCy_T168 spaCy_T165 appos ratios,T4
spaCy_R169 spaCy_T169 spaCy_T164 punct .,inversed
spaCy_R170 spaCy_T170 spaCy_T171 nsubj Patients,treated
spaCy_R171 spaCy_T171 spaCy_T171 ROOT treated,treated
spaCy_R172 spaCy_T172 spaCy_T171 advmod exclusively,treated
spaCy_R173 spaCy_T173 spaCy_T171 prep with,treated
spaCy_R174 spaCy_T174 spaCy_T173 pobj cryoprecipitate,with
spaCy_R175 spaCy_T175 spaCy_T174 cc or,cryoprecipitate
spaCy_R176 spaCy_T176 spaCy_T177 compound prothrombin,complex
spaCy_R177 spaCy_T177 spaCy_T174 conj complex,cryoprecipitate
spaCy_R178 spaCy_T178 spaCy_T179 nsubj concentrates,had
spaCy_R179 spaCy_T179 spaCy_T171 conj had,treated
spaCy_R180 spaCy_T180 spaCy_T181 amod normal,T4
spaCy_R181 spaCy_T181 spaCy_T179 dobj T4,had
spaCy_R182 spaCy_T182 spaCy_T181 punct :,T4
spaCy_R183 spaCy_T183 spaCy_T184 nummod T8,ratios
spaCy_R184 spaCy_T184 spaCy_T181 appos ratios,T4
spaCy_R185 spaCy_T185 spaCy_T184 cc and,ratios
spaCy_R186 spaCy_T186 spaCy_T187 compound platelet,counts
spaCy_R187 spaCy_T187 spaCy_T184 conj counts,ratios
spaCy_R188 spaCy_T188 spaCy_T179 punct .,had
spaCy_R189 spaCy_T189 spaCy_T190 det The,severity
spaCy_R190 spaCy_T190 spaCy_T197 nsubj severity,observed
spaCy_R191 spaCy_T191 spaCy_T190 prep of,severity
spaCy_R192 spaCy_T192 spaCy_T196 det the,abnormalities
spaCy_R193 spaCy_T193 spaCy_T196 amod haematological,abnormalities
spaCy_R194 spaCy_T194 spaCy_T193 cc and,haematological
spaCy_R195 spaCy_T195 spaCy_T193 conj immunological,haematological
spaCy_R196 spaCy_T196 spaCy_T191 pobj abnormalities,of
spaCy_R197 spaCy_T197 spaCy_T197 ROOT observed,observed
spaCy_R198 spaCy_T198 spaCy_T197 ccomp seems,observed
spaCy_R199 spaCy_T199 spaCy_T201 aux to,associated
spaCy_R200 spaCy_T200 spaCy_T201 auxpass be,associated
spaCy_R201 spaCy_T201 spaCy_T198 xcomp associated,seems
spaCy_R202 spaCy_T202 spaCy_T201 prep with,associated
spaCy_R203 spaCy_T203 spaCy_T204 amod high,usage
spaCy_R204 spaCy_T204 spaCy_T202 pobj usage,with
spaCy_R205 spaCy_T205 spaCy_T204 prep of,usage
spaCy_R206 spaCy_T206 spaCy_T205 pobj factor,of
spaCy_R207 spaCy_T207 spaCy_T208 nsubj VIII,concentrates
spaCy_R208 spaCy_T208 spaCy_T198 conj concentrates,seems
spaCy_R209 spaCy_T209 spaCy_T197 punct .,observed
spaCy_R210 spaCy_T210 spaCy_T211 amod Similar,abnormalities
spaCy_R211 spaCy_T211 spaCy_T214 nsubjpass abnormalities,described
spaCy_R212 spaCy_T212 spaCy_T214 aux have,described
spaCy_R213 spaCy_T213 spaCy_T214 auxpass been,described
spaCy_R214 spaCy_T214 spaCy_T214 ROOT described,described
spaCy_R215 spaCy_T215 spaCy_T214 prep in,described
spaCy_R216 spaCy_T216 spaCy_T215 pobj patients,in
spaCy_R217 spaCy_T217 spaCy_T214 prep with,described
spaCy_R218 spaCy_T218 spaCy_T222 det the,syndrome
spaCy_R219 spaCy_T219 spaCy_T221 amod acquired,deficiency
spaCy_R220 spaCy_T220 spaCy_T221 amod immune,deficiency
spaCy_R221 spaCy_T221 spaCy_T222 compound deficiency,syndrome
spaCy_R222 spaCy_T222 spaCy_T217 pobj syndrome,with
spaCy_R223 spaCy_T223 spaCy_T222 punct (,syndrome
spaCy_R224 spaCy_T224 spaCy_T222 appos AIDS,syndrome
spaCy_R225 spaCy_T225 spaCy_T222 punct ),syndrome
spaCy_R226 spaCy_T226 spaCy_T214 punct .,described
spaCy_R227 spaCy_T227 spaCy_T228 amod Prospective,study
spaCy_R228 spaCy_T228 spaCy_T232 nsubjpass study,required
spaCy_R229 spaCy_T229 spaCy_T228 prep of,study
spaCy_R230 spaCy_T230 spaCy_T229 pobj haemophiliacs,of
spaCy_R231 spaCy_T231 spaCy_T232 auxpass is,required
spaCy_R232 spaCy_T232 spaCy_T232 ROOT required,required
spaCy_R233 spaCy_T233 spaCy_T234 aux to,assess
spaCy_R234 spaCy_T234 spaCy_T232 xcomp assess,required
spaCy_R235 spaCy_T235 spaCy_T236 amod long,term
spaCy_R236 spaCy_T236 spaCy_T237 compound term,sequelae
spaCy_R237 spaCy_T237 spaCy_T234 dobj sequelae,assess
spaCy_R238 spaCy_T238 spaCy_T237 prep of,sequelae
spaCy_R239 spaCy_T239 spaCy_T241 compound factor,usage
spaCy_R240 spaCy_T240 spaCy_T241 compound concentrate,usage
spaCy_R241 spaCy_T241 spaCy_T238 pobj usage,of
spaCy_R242 spaCy_T242 spaCy_T237 punct ",",sequelae
spaCy_R243 spaCy_T243 spaCy_T237 prep including,sequelae
spaCy_R244 spaCy_T244 spaCy_T246 det the,development
spaCy_R245 spaCy_T245 spaCy_T246 amod possible,development
spaCy_R246 spaCy_T246 spaCy_T243 pobj development,including
spaCy_R247 spaCy_T247 spaCy_T246 prep of,development
spaCy_R248 spaCy_T248 spaCy_T247 pobj AIDS,of
spaCy_R249 spaCy_T249 spaCy_T232 punct .,required

oger-json-test

Id Subject Object Predicate Lexical cue
T1 0-10 CL:0000542 denotes Lymphocyte
T2 29-40 D005169 denotes factor VIII
T3 50-61 D006467 denotes haemophilia
T4 204-215 D006467 denotes haemophilia
T5 239-244 32644 denotes other
T6 245-253 D006470 denotes bleeding
T7 281-292 D005169 denotes factor VIII
T8 331-342 D006467 denotes haemophilia
T9 417-421 GO:0005623 denotes cell
T10 417-421 CL:0000000 denotes cell
T11 430-440 CL:0000542 denotes lymphocyte
T12 449-457 CL:0000233 denotes platelet
T13 494-502 GO:0019815 denotes antibody
T14 494-502 GO:0042571 denotes antibody
T15 494-502 GO:0003823 denotes antibody
T16 511-523 CL:0000084 denotes T lymphocyte
T17 513-523 CL:0000542 denotes lymphocyte
T18 576-587 D006467 denotes haemophilia
T19 588-593 Q01080 denotes A, 49
T20 633-649 D013921 denotes thrombocytopenia
T21 676-687 D005169 denotes factor VIII
T22 750-758 CL:0000233 denotes platelet
T23 771-781 CL:0000542 denotes lymphocyte
T24 875-886 D006467 denotes haemophilia
T25 893-904 D005169 denotes factor VIII
T26 905-915 CHEBI:35222 denotes inhibitors
T27 996-1007 P19221 denotes prothrombin
T28 996-1007 CHEBI:8583 denotes prothrombin
T29 996-1007 P00734 denotes prothrombin
T30 996-1007 Q5R537 denotes prothrombin
T31 996-1007 PR:000007299 denotes prothrombin
T32 996-1007 P18292 denotes prothrombin
T33 996-1007 D011516 denotes prothrombin
T34 996-1007 Q19AZ8 denotes prothrombin
T35 996-1007 P00735 denotes prothrombin
T36 996-1028 C025667 denotes prothrombin complex concentrates
T37 1008-1015 SO:0001784 denotes complex
T38 1057-1065 CL:0000233 denotes platelet
T39 1192-1203 D005169 denotes factor VIII
T40 1281-1316 D000163 denotes acquired immune deficiency syndrome
T41 1297-1307 SO:1000029 denotes deficiency
T42 1318-1322 D000163 denotes AIDS
T43 1387-1391 original_id denotes term
T44 1453-1464 GO:0032502 denotes development
T45 1468-1472 D000163 denotes AIDS